Evidence map›Paper›PMID 29851238›Full record

ArticleAcademic emergency medicine : official journal of the Society for Academic Emergency Medicine2018

Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-out Hepatitis C Virus Screening Program.

Elissa M Schechter-Perkins, Nancy S Miller, Jon Hall, Joshua J Hartman, David H Dorfman, Chris Andry, Benjamin P Linas

Abstract read
In one paragraph

Article in Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Hepatitis C Virus Reflex Testing Protocol in an Emergency Department.The western journal of emergency medicine · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Elissa M Schechter-PerkinsDepartment of Emergency Medicine, Boston University, School of Medicine and Boston Medical Center, Boston, MA.
Nancy S MillerDepartment of Pathology and Laboratory Medicine, Boston University, School of Medicine and Boston Medical Center, Boston, MA.
Jon HallDepartment of Internal Medicine/Section of Infectious Diseases, Boston University, School of Medicine and Boston Medical Center, Boston, MA.
Joshua J HartmanDepartment of Internal Medicine/Section of Infectious Diseases, Boston University, School of Medicine and Boston Medical Center, Boston, MA.
David H DorfmanDepartment of Pediatrics, Boston University, School of Medicine and Boston Medical Center, Boston, MA.
Chris AndryDepartment of Pathology and Laboratory Medicine, Boston University, School of Medicine and Boston Medical Center, Boston, MA.
Benjamin P LinasDepartment of Internal Medicine/Section of Infectious Diseases, Boston University, School of Medicine and Boston Medical Center, Boston, MA.

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorderP30DA040500 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Benjamin P. Linas · 2015 to 2026
$20.7M
Simulation Modeling to Improve HIV/HCV Screening, Treatment and CareR01DA031059 · NIDA · BOSTON MEDICAL CENTER · PI LINAS, BENJAMIN P. · 2012 to 2015
$2.1M
Center for Health Economics P30DA040500Gilead SciencesNIAID NIH HHS P30 AI042853NIDA NIH HHS P30 DA040500NIDA NIH HHS R01 DA031059Providence/Boston Center for AIDS Research P30AI042853
6 · The paper itself

Abstract

backgroundEmergency department (ED) visits provide an opportunity for hepatitis C virus (HCV) screening for patients who otherwise might not be tested. We report on a novel nontargeted, opt-out HCV screening and linkage-to-care (LTC) program implemented in an urban ED.

methodsThis is a descriptive analysis from 3 months (November 2016-January 2017) of a nontargeted, opt-out ED HCV screening and LTC program among patients at least 13 years old undergoing phlebotomy for clinical purposes. A multipurpose best practice advisory (BPA) alerted providers to the program and generated order labels. For patients who authorized testing, specimens were drawn in the ED for HCV antibody (Ab) and reflex confirmatory RNA tests. Public health navigators attempted to contact RNA-positive patients and arrange outpatient visits.

resultsHCV Ab tests were performed on 3,808 patients, a 6,950% increase from preprogram. The proportion of HCV Ab test positivity was 13.2% (504/3,808, 95% confidence interval [CI] = 12.2%-14.3%) and of those 97.8% (493/504) had a follow-up RNA test performed. A total of 292 were confirmed positive for active infection, for an overall RNA positivity rate of 7.7% (95% CI = 6.8%-8.5%). Of those with active infection, 155 (53%) were outside the Centers for Disease Control and Prevention birth cohort for increased risk for HCV including 46 (15.8%, 95% CI = 11.8%-20.4%) who also did not report injection drug use. Linkage attempts were documented on 223 (76.4%) patients and appointments were scheduled for 102 (38% of attempted). Sixty-six patients attended their LTC visit (22.5% of all RNA-positive patients, 30% of linkage-eligible patients).

conclusionsNontargeted opt-out HCV testing can be successfully implemented in an ED setting. A number of patients diagnosed were outside traditional risk groups. Once diagnosed, an ED population may be difficult to engage in care, but a structured interdisciplinary program can successfully link patients to HCV care.

Indexed as

AdolescentAdultEmergency Service, HospitalFemaleHepatitis CHepatitis C AntibodiesHumansMaleMass ScreeningMiddle AgedProgram DevelopmentRisk FactorsUnited StatesYoung AdultHepatitis C Antibodies

Identifiers

PMID29851238
PMCPMC6957127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.